menu
    • menu

    Company profile for ZACH System SA

    ZACH System-PSE
    News
    Zcube Announces 5 Startups For New Edition Focused Women's Health

    10 Oct 2024

    // PRESS RELEASE

    Zambon Ventures Leads C$2 million investment In Health Innovation

    24 Sep 2024

    // PRESS RELEASE

    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB

    13 Sep 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Zach System VB Read More

    Contact Supplier

    Website

    CPHI Middle east

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/pnQL6oDh-KQ

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Related CompaniesRelated Companies

    About

    Zach System, a subsidiary of Zambon Company, specializes in providing active pharmaceutical ingredients (APIs), intermediates and custom synthesis services that align with customers’ schedules and budget targets. It offers a diverse range of products and services for the generic drugs market, including producing APIs for Zambon Pharma and offering process development expertise to customers. Its facility in Avrillè, France, is cGMP compliant and approved by the FDA. The facility boasts reactors ranging from 50 litres to 10,000 litres, advanced technologies, and a state-of-the-art R&D center and QC labs, as well as a dedicated sales team.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZACH System SAFrance Flag
    Country
    Country
    France
    Address
    Address
    Z.l. la Croix Cadeau C.S 10079 49242 Avrille Cedex
    Telephone
    Telephone
    +33 676065210
    Client Email
    Email
    nicolas.girard@zambongroup.com
    Client Website
    Website
    https://www.zambon.com/en/production/zach-system
    Linkedin
    Linkedin
    https://in.linkedin.com/company/zach-system
    youtube
    YouTube
    https://www.youtube.com/channel/UCtibwDy2GE3-pFldM7AX5Cg
    Twitter
    Twitter
    https://x.com/zambonpharma
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPHI Middle east

    CPHI Middle east

    Not Confirmed

    envelop Contact Supplier

    CPHI Middle east

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-75640.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1583380114.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Results of Phase 3 PROMIS-I & PROMIS-II Studies 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-12292.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-62046.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pipeline

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1063.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Zach Digital Brochure

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1657779912.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Sophisticated Molecules

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1632832010.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Zcube Announces 5 Startups For New Edition Focused Women's Health
    Zcube Announces 5 Startups For New Edition Focused Women's Health

    10 Oct 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-09/open-accelerator-announces-5-startups-2024-program.pdf

    PRESS RELEASE
    10 Oct 2024
    Share Share
    Zambon Ventures Leads C$2 million investment In Health Innovation
    Zambon Ventures Leads C$2 million investment In Health Innovation

    24 Sep 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-09-24-zcube-zambon-research-venture-leads-c2-million-investment-round-canadian

    PRESS RELEASE
    24 Sep 2024
    Share Share
    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB
    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB

    13 Sep 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-09/240913_global_zambon_lancet-promis-1.pdf

    PRESS RELEASE
    13 Sep 2024
    Share Share
    Giovanni Magnaghi is the new Chief Executive Officer of Zambon SpA
    Giovanni Magnaghi is the new Chief Executive Officer of Zambon SpA

    02 May 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-05-02-giovanni-magnaghi-new-chief-executive-officer-zambon-spa

    PRESS RELEASE
    02 May 2024
    Share Share
    Zcube Launches 2024 Open Accelerator For Life Sciences Startups Focusing On Women's Health
    Zcube Launches 2024 Open Accelerator For Life Sciences Startups Focusing On Women's Health

    27 Feb 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-02/240227_ENG_Open%20Accelerator%202024%20Launch_DEF.pdf

    PRESS RELEASE
    27 Feb 2024
    Share Share
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203

    27 Feb 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-02-27-amneal-enters-exclusive-european-licensing-agreement-zambon-biotech-ipx203

    PRESS RELEASE
    27 Feb 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Acetylcysteine

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPHI Middle east
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-311 - Rev 00

    Issue Date : 2022-02-07

    Type : Chemical

    Substance Number : 967

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Not Available For Sales AUDIT
    Zach System VB Company banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Bosentan Hydrate

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPHI Middle east
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-08-25

    Pay. Date : 2014-01-31

    DMF Number : 24929

    Submission : 2011-05-09

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down
    ✖
    Available Reg. Filing : ASMF
    AUDIT
    Zach System VB Company banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Fosfomycin

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPHI Middle east
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-370 - Rev 03

    Issue Date : 2024-06-12

    Type : Chemical

    Substance Number : 1425

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Not Available For Sales AUDIT
    Zach System VB Company banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Loteprednol Etabonate

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPHI Middle east
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2024-10-16

    Pay. Date : 2024-10-08

    DMF Number : 11105

    Submission : 1994-09-26

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 60269-287

    Start Marketing Date : 1998-03-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT